Trial Summary
Research suggests that tACS is generally safe for humans, with studies highlighting its non-invasive nature and good tolerability. It has been used in various populations, including healthy adults and those with cognitive impairments, without significant safety concerns.
34589Active tACS (Transcranial Alternating Current Stimulation) is unique because it uses specific frequencies to modulate brain waves, potentially enhancing working memory by aligning with natural brain oscillations. Unlike other treatments, it is non-invasive, cost-effective, and has a promising safety profile, making it an attractive option for cognitive enhancement, especially in older adults and those with cognitive deficits.
24567Research suggests that tACS can have small-to-medium positive effects on working memory, especially when using specific frequencies like theta and gamma. These effects have been observed in both healthy adults and those with cognitive deficits, indicating potential for tACS as a non-drug method to enhance cognitive performance.
12457Yes, you will need to stop taking certain medications, especially those that affect brain stimulation, like psychotropic drugs and others that alter brain chemicals. It's best to discuss your specific medications with the trial team.
Eligibility Criteria
This trial is for individuals who can give informed consent and are fluent in English. It's designed to explore how working memory functions by using a noninvasive brain stimulation technique.Participant Groups
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline